Clinical Trials
3 trialsNCT02643303 2022-12-02
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Ludwig Institute for Cancer Research
Phase 1/2 Completed
NCT02423863 2020-12-17
Poly-ICLC
Oncovir, Inc.
Phase 2 Completed
NCT01984892 2018-01-23
Hiltonol
Icahn School of Medicine at Mount Sinai
Phase 2 Terminated